Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nevakar Injectables
Bridgewater, New Jersey, United Statesnevakarinjectables.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Nevakar Injectables has received FDA approvals for products including Ephedrine Sulfate Injection in prefilled syringe and Cyclophosphamide RTD Solution. Multiple programs filed under 505(b)(2) pathway with some out-licensed.[1][2][5][7]
- Therapeutic areas
- NeurologyOtherInfectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Endo PharmaceuticalsPar Sterile Products (Endo)NovaQuestH.I.G.
Beyond the preview
Go deeper on Nevakar Injectables.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nevakar Injectables.